04.07.2017 Treatment of hypertension helps to reduce the symptoms of Parkinson's disease
Previous studies have shown that Parkinson's disease is associated with hypertension. In addition, scientists said that some drugs lowering blood pressure, reduce the risk of Parkinson's disease. Experts from Great Britain and Italy have decided to find out whether the markers of Parkinson's disease are different in people with hypertension and without it, Zee News reports.
03.07.2017 Experts dispelled the common myth about IVF
Some believe that IVF is associated with decreased intelligence in children. However, experts from India say that children, conceived by means of reproductive technologies including IVF, have no differences in their level of cognitive development compared to those children who were conceived naturally, The Indian Express reports.
30.06.2017 Scientists revealed an enzyme that might defeat neurodegenerative diseases
Specialists from the University of South Florida have carried out a study in mice. The researchers have found that CyP40 enzyme protected the neurons of the experimental animals. It also relieved rodents of cognitive impairment and disintegrated the alpha-synuclein protein deposits associated with Parkinson's disease, Zee News reports.
29.06.2017 Infectious diseases in infancy increase the risk of gluten intolerance
A new study performed by the scientists of Helmholtz Munich Center has shown that infections occurred during the first year of life may cause celiac disease (gluten intolerance) at a later age. Most of all, the risk is increased due to GI infections, Zee News reports.
26.06.2017 Scientists say that Parkinson's disease is an autoimmune disease partially.
Scientists from the Columbia University Medical Center have confirmed the hypothesis that in Parkinson's disease, the body's immune system attacks its own healthy tissues. So, probably, the drugs that suppress immunity might help people suffering from Parkinson's disease, Zee News reports.
23.06.2017 Study has proved that amino acid helps to defeat herpes
Scientists from the National Institutes of Health of the United States have found that glutamine supplements (one of the 20 standard amino acids involved in the protein) prevent the reactivation of herpes simplex virus (HSV). Currently, there are no remedies for HSV-1 and HSV-2 causing oral and genital herpes, UPI.com reports.
22.06.2017 A unique drug may change the treatment of influenza
Johnson & Johnson has carried out a second phase of testing of its experimental drug against the influenza virus. The studies have shown that the drug significantly reduced the viral exposure to people with influenza. The code name of the drug is Pimodivir. The major task is to help patients who are resistant to treatment by standard methods, as well as patients hospitalized with influenza
21.06.2017 "Smart bacteria" will take care of the rehabilitation in heart sufferers
Stanford University has designed a new technique that will be capable to restore the heart after a heart attack in the short term. According to BBC, scientists suggest to introduce bacteria that produce oxygen as a result of photosynthesis. Currently, the method was tested in rats. So, if a thrombus blocks a vessel, the heart experiences the oxygen starvation due to disturbed blood flow. But when a single-celled cyanobacterium Synechococcus elongatus capable of photosynthesis was implanted, it is possible to remove carbon dioxide and saturate the muscle cells in the heart with oxygen and sugar simultaneously.
20.06.2017 As it turned out, unusual bacteria are the source of powerful antibiotic
Scientists have discovered a natural antibiotic that can cope with resistant tuberculosis. According to News -medical.net, for example, in Russia by 2040, more than a third of all cases of tuberculosis will be sustainable. Therefore, a research for new drugs is necessary.
19.06.2017 Scientists on the verge of victory against Parkinson's disease
Scientists from the University of California have created a molecular compound for the control of Parkinson's disease - CLR01. It has been already tested on mice suffering from this neurodegenerative disease. CLR01 reduces the level of the toxic protein (alpha-synuclein) in the brain. This protein is associated with the development of Parkinson's disease, UPI.com reports.